Osimertinib before and after chemoradiotherapy for unresectable stage III EGFR-mutated NSCLC: NEOLA Trial Protocol.

ABSTRACT:

Clinical trial registration

ClinicalTrials.gov identifier is NCT06194448 (date of registration 5 January 2024).

SUBMITTER: Aredo JV 

PROVIDER: S-EPMC12688264 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature